Priorities in reducing child mortality: Azithromycin and other interventions
- PMID: 32931499
- PMCID: PMC7491718
- DOI: 10.1371/journal.pmed.1003364
Priorities in reducing child mortality: Azithromycin and other interventions
Abstract
In this Perspective, David Mabey and colleagues discuss a recent PLOS Medicine article on azithromycin as an intervention for reducing child mortality.
Conflict of interest statement
The authors have declared that no competing interests exist.
Comment on
-
Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger.PLoS Med. 2020 Sep 15;17(9):e1003285. doi: 10.1371/journal.pmed.1003285. eCollection 2020 Sep. PLoS Med. 2020. PMID: 32931496 Free PMC article. Clinical Trial.
References
-
- Under five mortality. Global Health Observatory (GHO) data. World Health Organization; website. [cited 2020 Aug 21]. https://www.who.int/gho/child_health/mortality/mortality_under_five_text....
-
- Keenan JD, Arzika AM, Maliki R, Adamou SE, Ibrahim F, Kiemago M et al. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial. Lancet Glob Health 2020; 8: e288–e95. - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
